World’s best-selling drug costs five times more in U.S. than Europe

Critics accuse the maker of Humira of exploiting patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NBCNews /  🏆 10. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Even the best stock-market investors fail when it’s time to sellEven the best stock-market investors fail when it’s time to sell (via MktwHulbert)
Consulte Mais informação »

As medical costs mount, Japan to weigh cost-effectiveness in setting drug pricesJapanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an ...
Consulte Mais informação »

I drove the world's best-selling electric car for a weekend — and I realized why electric cars need more than 200 miles of rangeI drove the 2018 Nissan Leaf for a weekend in December.
Consulte Mais informação »